194 related articles for article (PubMed ID: 19064569)
21. Paraffin-embedded tissue is less accurate than frozen section analysis for determining VHL mutational status in sporadic renal cell carcinoma.
Verhoest G; Patard JJ; Fergelot P; Jouan F; Zerrouki S; Dreano S; Mottier S; Rioux-Leclercq N; Denis MG
Urol Oncol; 2012; 30(4):469-75. PubMed ID: 20863722
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
[TBL] [Abstract][Full Text] [Related]
23. von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma.
Choueiri TK; Vaziri SA; Jaeger E; Elson P; Wood L; Bhalla IP; Small EJ; Weinberg V; Sein N; Simko J; Golshayan AR; Sercia L; Zhou M; Waldman FM; Rini BI; Bukowski RM; Ganapathi R
J Urol; 2008 Sep; 180(3):860-5; discussion 865-6. PubMed ID: 18635227
[TBL] [Abstract][Full Text] [Related]
24. Identification of somatic mutations in the von Hippel-Lindau (VHL) gene in a patient with renal cell carcinoma.
Wang WC; Chen HJ; Tseng YH; Lai YC
J Formos Med Assoc; 2009 Nov; 108(11):886-93. PubMed ID: 19933033
[TBL] [Abstract][Full Text] [Related]
25. Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity.
Trotta AM; Santagata S; Zanotta S; D'Alterio C; Napolitano M; Rea G; Camerlingo R; Esposito F; Lamantia E; Anniciello A; Botti G; Longo N; Botti G; Pignata S; Perdonà S; Scala S
J Exp Clin Cancer Res; 2018 Dec; 37(1):297. PubMed ID: 30514329
[TBL] [Abstract][Full Text] [Related]
26. Prognostic and predictive value of VHL gene alteration in renal cell carcinoma: a meta-analysis and review.
Kim BJ; Kim JH; Kim HS; Zang DY
Oncotarget; 2017 Feb; 8(8):13979-13985. PubMed ID: 28103578
[TBL] [Abstract][Full Text] [Related]
27. Detection of circulating cancer cells with von hippel-lindau gene mutation in peripheral blood of patients with renal cell carcinoma.
Ashida S; Okuda H; Chikazawa M; Tanimura M; Sugita O; Yamamoto Y; Nakamura S; Moriyama M; Shuin T
Clin Cancer Res; 2000 Oct; 6(10):3817-22. PubMed ID: 11051223
[TBL] [Abstract][Full Text] [Related]
28. Somatic VHL alteration and its impact on prognosis in patients with clear cell renal cell carcinoma.
Kim JH; Jung CW; Cho YH; Lee J; Lee SH; Kim HY; Park J; Park JO; Kim K; Kim WS; Park YS; Im YH; Kang WK; Park K
Oncol Rep; 2005 May; 13(5):859-64. PubMed ID: 15809750
[TBL] [Abstract][Full Text] [Related]
29. Novel mutations of the von hippel-lindau tumor-suppressor gene and rare DNA hypermethylation in renal-cell carcinoma cell lines of the clear-cell type.
Meyer AJ; Hernandez A; Florl AR; Enczmann J; Gerharz CD; Schulz WA; Wernet P; Ackermann R
Int J Cancer; 2000 Sep; 87(5):650-3. PubMed ID: 10925357
[TBL] [Abstract][Full Text] [Related]
30. Different angiogenic potential in low and high grade sporadic clear cell renal cell carcinoma is not related to alterations in the von Hippel-Lindau gene.
Baldewijns MM; van Vlodrop IJ; Smits KM; Vermeulen PB; Van den Eynden GG; Schot F; Roskams T; van Poppel H; van Engeland M; de Bruïne AP
Cell Oncol; 2009; 31(5):371-82. PubMed ID: 19759417
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms in the Von Hippel-Lindau Gene Are Associated With Overall Survival in Metastatic Clear-Cell Renal-Cell Carcinoma Patients Treated With VEGFR Tyrosine Kinase Inhibitors.
Verbiest A; Lambrechts D; Van Brussel T; Couchy G; Wozniak A; Méjean A; Lerut E; Oudard S; Verkarre V; Job S; de Reynies A; Machiels JP; Patard JJ; Zucman-Rossi J; Beuselinck B
Clin Genitourin Cancer; 2018 Aug; 16(4):266-273. PubMed ID: 29503246
[TBL] [Abstract][Full Text] [Related]
32. Promoter CpG island methylation in ion transport mechanisms and associated dietary intakes jointly influence the risk of clear-cell renal cell cancer.
Deckers IA; van Engeland M; van den Brandt PA; Van Neste L; Soetekouw PM; Aarts MJ; Baldewijns MM; Keszei AP; Schouten LJ
Int J Epidemiol; 2017 Apr; 46(2):622-631. PubMed ID: 27789672
[TBL] [Abstract][Full Text] [Related]
33. Molecular detection of von Hippel-Lindau gene mutations in urine and lymph node samples in patients with renal cell carcinoma: potential biomarkers for early diagnosis and postoperative metastatic status.
Ashida S; Furihata M; Tanimura M; Sugita O; Yamashita M; Miura T; Moriyama M; Shuin T
J Urol; 2003 Jun; 169(6):2089-93. PubMed ID: 12771725
[TBL] [Abstract][Full Text] [Related]
34. Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with early-stage clear cell renal cell carcinoma.
Parker AS; Cheville JC; Lohse CM; Igel T; Leibovich BC; Blute ML
Urology; 2005 Jun; 65(6):1090-5. PubMed ID: 15893810
[TBL] [Abstract][Full Text] [Related]
35. Expression of fibronectin and HIF-1alpha in renal cell carcinomas: relationship to von Hippel-Lindau gene inactivation.
He Z; Liu S; Guo M; Mao J; Hughson MD
Cancer Genet Cytogenet; 2004 Jul; 152(2):89-94. PubMed ID: 15262424
[TBL] [Abstract][Full Text] [Related]
36. [Alteration of VHL gene in patients with metastatic renal cell carcinoma].
Peters MV; Matveev VB; Volkova MI; Kalinin SA; Mikhaĭlenko DM
Urologiia; 2012; (3):22-7. PubMed ID: 23074928
[TBL] [Abstract][Full Text] [Related]
37. [Correlation of cyclin D1 overexpression to mutations of von hippel-lindau gene in renal clear cell carcinoma].
Ren YY; Du LJ; Feng ZQ; Leng J
Ai Zheng; 2006 Feb; 25(2):175-8. PubMed ID: 16480581
[TBL] [Abstract][Full Text] [Related]
38. VHL gene alterations in renal cell carcinoma patients: novel hotspot or founder mutations and linkage disequilibrium.
Ma X; Yang K; Lindblad P; Egevad L; Hemminki K
Oncogene; 2001 Aug; 20(38):5393-400. PubMed ID: 11536052
[TBL] [Abstract][Full Text] [Related]
39. Allelic loss analysis of tumor suppressor genes regardless of heterozygosity: von Hippel-Lindau gene loss in renal cell carcinoma.
Mochida J; Esumi M; Kitajima A; Okada K
J Urol; 2008 Aug; 180(2):724-8. PubMed ID: 18554638
[TBL] [Abstract][Full Text] [Related]
40. No evidence for DNA methylation of von Hippel-Lindau ubiquitin ligase complex genes in breast cancer.
Huang KT; Dobrovic A; Fox SB
Breast Cancer Res Treat; 2010 Dec; 124(3):853-6. PubMed ID: 20680678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]